Medical marijuana for symptoms in patients with multiple sclerosis

This study analyzed 17 clinical trials including 3,161 patients to evaluate medicinal cannabinoids -- the chemical compounds in cannabis -- for the treatment of symptoms in patients with   multiple sclerosis (MS). Cannabinoids were associated with a limited and mild reduction in the subjective patient assessment of spasticity (contracted muscles), pain and bladder dysfunction in this systematic review and meta-analysis.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news